Trials / Completed
CompletedNCT00860340
Hemodynamic Effects of Spironolactone in Patients With Heart Failure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- University of Toledo Health Science Campus · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To determine if the beneficial effect of spironolactone in patients with congestive heart failure is in part due to its intrinsic inotropic action. Randomized, two group placebo controlled, single blind study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Spironolactone | 100 mg tablet of Spironolactone (Aldactone) by mouth with half a glass of water. |
Timeline
- Start date
- 2003-02-01
- Primary completion
- 2006-10-01
- Completion
- 2006-10-01
- First posted
- 2009-03-12
- Last updated
- 2014-12-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00860340. Inclusion in this directory is not an endorsement.